Exhibitors Search
ATEMs
| Exhibition | NextRegenX |
|---|---|
| Booth no. | B52 |
| Country | Korea, South |
| Address | 7 Jeongui-ro 8-gil, Songpa-gu, Seoul, Republic of Korea |
| Tel (Rep.) | 02-401-7943 |
| Website | http://www.atems.co.kr |
Company Introduction
1. Mission : ATEMs Provides Human with the Joy of Activity
2. Platform: Development of degenerative and intractable disease therapy
- Main Platform: Provide total solutions for all grades of osteoarthritis
3. Pipeline
- Tissue Engineering Therapy (A-Paste)
: A-Paste-C (Knee)/ A-Paste-D (Disc)/ A-Paste-GP(Growth Plate)/ Bio-cartilage Replacement
- Biomaterial Medical Device (CAM/ ADM)
: CartiSave (Intraarticular )/ TenoSave (Ligament, Tendon) / EssenDerm (Skin)/ ADM Solution ( Skin booster)
2. Platform: Development of degenerative and intractable disease therapy
- Main Platform: Provide total solutions for all grades of osteoarthritis
3. Pipeline
- Tissue Engineering Therapy (A-Paste)
: A-Paste-C (Knee)/ A-Paste-D (Disc)/ A-Paste-GP(Growth Plate)/ Bio-cartilage Replacement
- Biomaterial Medical Device (CAM/ ADM)
: CartiSave (Intraarticular )/ TenoSave (Ligament, Tendon) / EssenDerm (Skin)/ ADM Solution ( Skin booster)
Promotional video
Exhibit Item
A-Paste-C (Tissue Regenerative Medicine : Knee Cartilage ), CariSave (Biomaterial Medical Device: Intra-articular injection)
Exhibit Description
1. A-Paste-C (Tissue Engineering Therapy: Cartilage Defect Regeneration ,Phase 1 Clinical)
: Injectable gel 3D cartilage tissue consist of fetal chondrocyte
2. CariSave(Biomaterial Medical Device: Intraarticular Collagen Injection, Approval expected Feb. 24')
; Cartilage-derived ECM (collagen type II+ proteoglycan). Grade 4 medical device.
: Injectable gel 3D cartilage tissue consist of fetal chondrocyte
2. CariSave(Biomaterial Medical Device: Intraarticular Collagen Injection, Approval expected Feb. 24')
; Cartilage-derived ECM (collagen type II+ proteoglycan). Grade 4 medical device.
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|

KYUNGYON EXHIBITION CORP.